首页|Krüppel样转录因子8与乳腺癌他莫昔芬耐药的相关性

Krüppel样转录因子8与乳腺癌他莫昔芬耐药的相关性

扫码查看
目的:探讨Krüppel样转录因子 8(KLF8)与乳腺癌他莫昔芬(TAM)耐药及预后的相关性.方法:利用公共数据库分析KLF8 mRNA在TAM敏感与耐药细胞中的表达差异及KLF8 mRNA对接受TAM治疗乳腺癌患者预后的影响.运用RT-PCR及Western印迹方法检测MCF-7与LCC2 细胞中KLF8 mRNA及蛋白表达差异,免疫组化检测97 例 Luminal A/B 亚型接受TAM治疗乳腺癌中KLF8 表达情况并分析其与预后的关系,运用CCK-8 试剂盒检测沉默及过表达KLF8 后在不同浓度TAM作用下细胞增殖变化.结果:TAM耐药细胞中KLF8 表达水平高于TAM敏感细胞,接受TAM治疗Luminal A/B亚型乳腺癌患者中,KLF8 高表达者预后差,过表达KLF8 后细胞对TAM耐药性增强,而沉默KLF8 后细胞对TAM耐药性减弱.结论:KLF8 高表达与乳腺癌TAM耐药正相关,在 Luminal A/B 亚型的乳腺癌中,KLF8 高表达TAM治疗效果差,KLF8 或可成为TAM疗效判断及逆转耐药的新靶点.
The relationship between Kruppel-like transcription factor 8 and tamoxifen resistance in breast cancer
Objective To investigate the relationship of Krüppel-like factor 8(KLF8)on tamoxifen(TAM)resistance and prognosis of breast cancer.Method The expression difference of KLF8 mRNA in TAM sensitive vs drug resistant cells and the effect of KLF8 mRNA on prognosis of breast cancer patients treated with TAM were analyzed using public database.RT-PCR and Western blot were used to detect the expression differences of KLF8 mRNA and protein between MCF-7 and LCC2 cells.Immunohistochemistry was used to detect KLF8 expression in 97 patients was Luminal A/B subtype treated with TAM,and to analyze the relationship between KLF8 expression and prognosis.CCK-8 kit was used to detect the changes of cell proliferation under different concentrations of TAM after si-lencing or overexpressing KLF8.Results The expression level of KLF8 in TAM resistant cells was higher than that in TAM sensitive cells.In patients with Luminal A/B subtype breast cancer treated with TAM,patients with high KLF8 expression had poor prognosis,and the resistance to TAM was enhanced after overexpression of KLF8,while the resistance to TAM was weakened after silence of KLF8.Conclusion The high expression of KLF8 is associated with tamoxifen resistance in breast cancer.In Luminal A/B subtype of breast cancer,the high expression of KLF8 TAM has poor therapeutic effect.KLF8 may predict efficacy of tamoxifen and provide a new entry point for molecular targeted therapy.

Breast cancerTamoxifenDrug resistanceKrüppel-like factor 8

孙任成、于渊

展开 >

潍坊市中医院肿瘤外科,山东 潍坊 261041

潍坊市人民医院肿瘤内科

乳腺癌 他莫昔芬 耐药 Krüppel样转录因子8

潍坊市卫生健康委员会资助项目

WFWSJK-2021-116

2024

吉林医学
吉林省人民医院

吉林医学

影响因子:0.926
ISSN:1004-0412
年,卷(期):2024.45(5)
  • 25